OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I-II Study of Radiopeptide 177 Lu-Octreotate in Combination with Capecitabine and Temozolomide in Advanced Low-Grade Neuroendocrine Tumors

HTML

Year: 2012
Type: article
Study design: Clinical Trial
Source: Cancer Biotherapy and Radiopharmaceuticals
DOI: 10.1089/cbr.2012.1276
Authors: Phillip G. Claringbold, Richard A. Price, J. Harvey Turner
Institutions: The University of Western Australia, Fremantle Hospital
Language: English

Topic: Neuroendocrine Tumor Research Advances
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: capecitabine, temozolomide, low-grade neuroendocrine tumor, gastroenteropancreatic neuroendocrine tumors, peptide receptor radionuclide therapy, combination chemotherapy, treatment toxicity, progression-free survival, overall survival, objective response rate, dose escalation, thrombocytopenia, neutropenia
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2012856564
FWCI: 4.741
Cites: 27
Cited by: 180
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms